Demonstration of the safety and efficacy of CL-108 for moderate-to-severe pain with reduction of opioid-induced nausea and vomiting

Schachtel B, Younes N, Zhou J, Schachtel E, Hersh E. Demonstration of the safety and efficacy of CL-108 for moderate-to-severe pain with reduction of opioid-induced nausea and vomiting. J Pain 2014;15(4): S81.